SKYE · Skye Bioscience, Inc. · Congressional Trades
$1.02
-0.01 (-1.36%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If adequate funds are not available to the Company when needed it will be required to curtail or perhaps cease operations which would, in turn, further raise substantial doubt about its ability to continue as a going concern. These conditions give rise to substantial doubt as to the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$4.56M
Shares
4.42M
Volume · Nov 19
12.7K
Avg daily vol (62 sessions)
84.15K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1516551
CUSIP
83086J309
13F (30d)
32 filings
29 filers
Visit website
Investor relations